Development of a New Prognostic Assessment Tool for Postoperative Myocardial Injury (TROPUTILE)

August 6, 2024 updated by: University Hospital, Brest

Development of a New Prognostic Assessment Tool for Postoperative Myocardial Injury : the TROPUTILE Score. A Non-interventional Prospective Study

Myocardial injury after noncardiac surgery (MINS) is common, silent, and strongly associated with morbi-mortality.

There are some evidences in the littérature showing that troponin elevation pre and/or postoperatively and surgical Apgar score are strongly and independently associated with postoperative morbi-mortality.

In this cohort study of orthopedic surgery patients (> 50years), the aim is to determine MINS incidence and to assess wich peri-operative factors are associated with the occurrence of MINS. The final objective is to create a score to better identified the patients with a MINS and a poor outcome.

Study Overview

Status

Recruiting

Study Type

Observational

Enrollment (Estimated)

1600

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years to 100 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

Patients aged of 50 years and more, with elective orthopedic surgery in Brest community-affiliated hospital

Description

Inclusion Criteria:

  • > 50 years
  • orthopedic surgery (hip, knee, spine)
  • written consent

Exclusion Criteria:

  • no troponin measurement prior surgery
  • sepsis
  • acute coronary syndrome
  • pulmonary embolism
  • refusing to participate
  • guardianship

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative MINS incidence
Time Frame: 3 days after surgery
Troponin elevation > 5ng/l compared to previous measurement OR troponin elevation > 65 ng/l
3 days after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of Participants with cardiac arrest
Time Frame: 3 months
Cardiac arrest
3 months
Number of Participants with an episode of acute pulmonary oedema
Time Frame: 3 months
Acute pulmonary oedema
3 months
Number of Participants with coronary angioplasty
Time Frame: 3 months
Coronary angioplasty
3 months
Number of Participants with myocardial infarction
Time Frame: 3 months
Myocardial infarction
3 months
Number of Participants with stroke
Time Frame: 3 months
Stroke
3 months
Number of Participants with transient stroke
Time Frame: 3 months
Transient stroke
3 months
Mortality rate
Time Frame: 3 months
Death
3 months
Revised Cardiac Risk Index for Pre-Operative Risk (Lee score)
Time Frame: Inclusion
Minimum value = 0 Minimum value = 0, maximum value = 6, higher scores mean a worse outcome (higher peri operative mortality risk)
Inclusion
Metabolic Equivalent of Task (MET)
Time Frame: Inclusion
Minimum value = 1, Maximum value= 10, a low score (MET <4) is associated with a capacity to do some light intensity activities and is associated with cardiovascular risk.
Inclusion

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Olivier HUET, MD, PhD, CHRU Brest

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 7, 2020

Primary Completion (Estimated)

April 7, 2025

Study Completion (Estimated)

April 7, 2025

Study Registration Dates

First Submitted

February 25, 2020

First Submitted That Met QC Criteria

February 25, 2020

First Posted (Actual)

February 27, 2020

Study Record Updates

Last Update Posted (Actual)

August 7, 2024

Last Update Submitted That Met QC Criteria

August 6, 2024

Last Verified

December 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 29BRC19.0202 (TROPUTILE)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

All collected data that underlie results in a publication

IPD Sharing Time Frame

Data will be available beginning 21 months and ending five years following the publication

IPD Sharing Access Criteria

Data access requests will be reviewed by the international committee of Brest UH . Requestors will be required to sign and complete a data acess agreement

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Myocardial Injury

Subscribe